Cabergoline Tablet
Product Images NDC 23155-823

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 23155-823). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D3e8a769 Cb6d 469c 9bf7 3fe577028668 01)

Chemical structure of cabergoline, showing its molecular framework with multiple rings and functional groups, including amide and amine groups as part of its composition.*

FDA Label Image

Logo (D3e8a769 Cb6d 469c 9bf7 3fe577028668 02)

FDA Label Image

Label (D3e8a769 Cb6d 469c 9bf7 3fe577028668 03)

Cabergoline 0.5 mg tablets, USP, oral dosage form, contained in a package of 8 tablets for prescription use only. The label displays the proprietary name Cabergoline, strength 0.5 mg, and manufacturer Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. Additional information includes storage instructions, child safety warnings, NDC 23155-823, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.